Safety of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: A Longitudinal Analysis - Quiz - MDSpire

Safety of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: A Longitudinal Analysis

  • By

  • Kuan Peng

  • Vincent K. C. Yan

  • Shirley C. W. Chan

  • Ju-Young Shin

  • Edward Chia‑Cheng Lai

  • Nicole L. Pratt

  • Esther W. Y. Chan

  • Chak-sing Lau

  • Xue Li

  • June 26, 2026

  • 0 min

Share

Original Source(s)

Safety of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: A Longitudinal Analysis

  • by Kuan Peng, Vincent K. C. Yan, Shirley C. W. Chan, Ju-Young Shin, Edward Chia‑Cheng Lai, Nicole L. Pratt, Esther W. Y. Chan, Chak-sing Lau, Xue Li

  • June 26, 2026

Related Content

Comparison of efficacy and cost-effectiveness between mobile-bearing and fixed-bearing unicompartmental knee arthroplasty for elderly patients with knee osteoarthritis: a retrospective cohort study

Case report: Pediatric vascular Behçet’s disease with prominent arterial involvement: a case series of five patients

Side Effects: Sour Mouth, Lower BP

Acidic gum beat sugar-free at cranking out nitric oxide from beetroot juice — exactly backward from what test-tube studies predicted. Also this week: a sleep gene that ignores amyloid, and jackfruit sap moonlighting as a bone-building drug delivery system.